Initiatives & Task Force Reports

ACNP Initiatives

ACNP Statement on Clinical Trials Registries (PDF 19Kb)

Through its official activities and the efforts of its membership, the College will work to ensure that the highest quality of science and ethics are integral to the conduct of clinical trials in our field.

Code of Conduct for Supporting Corporations (PDF 25Kb)

In April 2006, The American College of Neuropsychopharmacology (ACNP) Council endorsed this Code of Conduct for its supporting corporations and their designated representatives.

Roles and Responsibilities for Supporting Corporations (PDF 27Kb)

The ACNP has committed itself to establish effective, collaborative relationships with patient advocacy organizations, government, academia, and industry that help to advance the scientific goals of the College, and to serve as a catalyst for collaborative work to advance discovery and disseminate scientific advances.

Task Force Reports

ACNP Statement to IOM Committee on the Assessment of US Drug Safety System

Presented by Donald F. Klein, MD

ACNP Task Force on Industry Publications Report to Council (PDF 5390Kb)

Council appreciates the work done by the Task Force on Industry Publication in preparing this report. The report is being made available only to ACNP members for their review. Members may want to share their comments on the report with Council. That can be done by sending an email to acnp@acnp.org and indicate “Comments on report on industry publication” in the email subject line.
Source: ACNP Task Force on Industry Publications

Annual Meeting Task Force Report

Qualitative and Quantitative Research to Gather Data from the ACNP Membership on the Content, Structure, Time, and Location of the Annual Meeting
Source: Innovation Management
Apr 2, 2007

SSRIs and Suicide in Youth

ACNP Task Force Report on SSRIs and Suicidal Behavior in Youth

Task Force Report on Terrorism (PDF 91Kb)

The impact of terrorism on brain and brain behavior: What we know and what we need to know
Apr 21, 2004

Use of Antipsychotic Drugs (PDF 177Kb)

ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia
Source: Neuropsychpharmacology (2007), 1-14

User Name:
Password:

Forgot your user name or password?
Remember me.